CVC moves to take Recordati private in $12.6bn buyout proposal
CVC Capital Partners has submitted a non-binding offer to acquire full control of Recordati, valuing the Italian pharmaceutical group at €10.9bn, equivalent to approximately $12.6bn, according to Reuters.
The proposed offer of €52 per share represents a premium to the current trading price and follows earlier market speculation that drove Recordati’s shares higher.
CVC, which already owns a 46.8% stake in the business, is seeking to delist the company through a full takeover, reinforcing its long-term commitment to the asset.
The transaction remains subject to due diligence, financing arrangements, and the identification of additional investors to support the deal.
The move highlights continued private equity interest in healthcare assets, particularly established pharmaceutical platforms with strong cash flows and global reach.
The proposal also reflects broader trends of public-to-private transactions, as buyout firms seek to capitalise on valuation opportunities in public markets.
If completed, the deal would rank among the largest private equity-backed takeovers in Europe’s healthcare sector in recent years.
The outcome will depend on further negotiations and regulatory approvals, as well as broader market conditions affecting financing and investor participation.
If you think we missed any important news, please do not hesitate to contact us at [email protected].
Can`t stop reading? Read more.
